YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

A Brick Township native is sharing his story on how kindness saved his life while fighting a rare neurological disorder. Keith Rella was living a normal life as a husband and father when he suddenly ...

As per the order based on insights from the National Centre for Vector Borne Disease Control, dengue and chikungunya are now ...

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

Bryan Johnson referred to this latest move as a version 2.0 of an earlier experiment where he received plasma from his son ...

Sarah Susak, 48, has faced an ordeal battling cancer which included medical professionals telling her she may have to have a ...

Adopting cleanliness, checking mosquito breeding sites, and spreading awareness are key measures to curb the spread of dengu ...

Arcellx, Inc. , a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced new ...

The indie singer-songwriter announced his diagnosis in 2023 with a photo of himself in a wheelchair Sufjan Stevens gave a ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in ...